美国食品药品监督管理局不良事件报告系统数据库中的“极度重复”现象。 - Suppr

Suppr

超能文献

'Extreme duplication' in the US FDA Adverse Events Reporting System database.

作者信息

Hauben Manfred, Reich Lester, DeMicco James, Kim Katherine

出版信息

Drug Saf. 2007;30(6):551-4. doi: 10.2165/00002018-200730060-00009.

DOI:10.2165/00002018-200730060-00009

PMID:17536881

Abstract

摘要

相似文献

'Extreme duplication' in the US FDA Adverse Events Reporting System database.美国食品药品监督管理局不良事件报告系统数据库中的“极度重复”现象。

Drug Saf. 2007;30(6):551-4. doi: 10.2165/00002018-200730060-00009.

Data incompatibility of adverse event reports electronically submitted to the AERS database.电子提交至AERS数据库的不良事件报告的数据不兼容性。

Pharmacoepidemiol Drug Saf. 2008 Feb;17(2):212-3. doi: 10.1002/pds.1537.

Comment on: Botulinum Toxin Type A Overdoses: Analysis of the FDA Adverse Event Reporting System Database.评论：A型肉毒杆菌毒素过量：对美国食品药品监督管理局不良事件报告系统数据库的分析

Clin Drug Investig. 2018 Dec;38(12):1197-1198. doi: 10.1007/s40261-018-0723-4.

Response to "Comment on: Botulinum Toxin Type A Overdoses: Analysis of the FDA Adverse Event Reporting System Database".对《关于A型肉毒毒素过量：美国食品药品监督管理局不良事件报告系统数据库分析》评论的回应

Clin Drug Investig. 2018 Dec;38(12):1199-1200. doi: 10.1007/s40261-018-0724-3.

Completeness of serious adverse drug event reports received by the US Food and Drug Administration in 2014.美国食品药品监督管理局2014年收到的严重药品不良事件报告的完整性。

Pharmacoepidemiol Drug Saf. 2016 Jun;25(6):713-8. doi: 10.1002/pds.3979. Epub 2016 Feb 10.

Data mining differential clinical outcomes associated with drug regimens using adverse event reporting data.利用不良事件报告数据挖掘与药物治疗方案相关的不同临床结果。

Nat Biotechnol. 2016 Jul 12;34(7):697-700. doi: 10.1038/nbt.3623.

Quality assessment of spontaneous triggered adverse event reports received by the Food and Drug Administration.自发触发不良事件报告的质量评估，这些报告由食品和药物管理局收到。

Pharmacoepidemiol Drug Saf. 2012 Jun;21(6):565-70; discussion 571-2. doi: 10.1002/pds.3223. Epub 2012 Feb 22.

A Pharmacovigilance Signaling System Based on FDA Regulatory Action and Post-Marketing Adverse Event Reports.一种基于美国食品药品监督管理局监管行动和上市后不良事件报告的药物警戒信号系统。

Drug Saf. 2016 Jun;39(6):561-75. doi: 10.1007/s40264-016-0409-x.

Drug-versus-drug adverse event rate comparisons: a pilot study based on data from the US FDA Adverse Event Reporting System.药物与药物不良事件发生率比较：一项基于美国食品药品监督管理局不良事件报告系统数据的试点研究。

Drug Saf. 2009;32(2):137-46. doi: 10.2165/00002018-200932020-00006.

Miscategorization of Deaths in the US Food and Drug Administration Adverse Events Database.美国食品和药物管理局不良事件数据库中死亡病例的分类错误。

JAMA Intern Med. 2020 Jan 1;180(1):147-148. doi: 10.1001/jamainternmed.2019.4030.

引用本文的文献

Insulin and Metformin are Associated With Reduced Risk of Amyotrophic Lateral Sclerosis.胰岛素和二甲双胍与降低肌萎缩侧索硬化症风险相关。

Chronic Dis Transl Med. 2024 Jun 30;11(2):148-155. doi: 10.1002/cdt3.141. eCollection 2025 Jun.

An Evaluation of Duplicate Adverse Event Reports Characteristics in the Food and Drug Administration Adverse Event Reporting System.食品药品监督管理局不良事件报告系统中重复不良事件报告特征的评估

Drug Saf. 2025 Jun 4. doi: 10.1007/s40264-025-01560-7.

Challenges and Innovations in Pharmacovigilance and Signal Management During the COVID-19 Pandemic: An Industry Perspective.新冠疫情期间药物警戒与信号管理的挑战与创新：行业视角

Vaccines (Basel). 2025 Apr 29;13(5):481. doi: 10.3390/vaccines13050481.

FDA Adverse Event Reporting System (FAERS) Essentials: A Guide to Understanding, Applying, and Interpreting Adverse Event Data Reported to FAERS.美国食品药品监督管理局不良事件报告系统（FAERS）要点：解读、应用及阐释向FAERS报告的不良事件数据指南

Clin Pharmacol Ther. 2025 Sep;118(3):567-582. doi: 10.1002/cpt.3701. Epub 2025 May 19.

Might We Come Together on a Paradigm Shift to Manage ICSRs with a Decentralized Data Model?我们能否就范式转变达成共识，采用分散数据模型来管理ICSR（个体病例安全报告）？

Drug Saf. 2025 Mar 8. doi: 10.1007/s40264-025-01539-4.

Amlodipine increases risk of primary open-angle glaucoma.氨氯地平会增加原发性开角型青光眼的风险。

Clin Hypertens. 2024 Nov 1;30(1):33. doi: 10.1186/s40885-024-00290-9.

Infection associated with CDK4/6 inhibitors: a pharmacovigilance analysis of the FDA adverse event reporting system database.与细胞周期蛋白依赖性激酶4/6（CDK4/6）抑制剂相关的感染：对美国食品药品监督管理局不良事件报告系统数据库的药物警戒分析

Front Pharmacol. 2024 Jul 1;15:1371346. doi: 10.3389/fphar.2024.1371346. eCollection 2024.

Salbutamol, a Short Acting Beta-2 Agonist, Reduces Risk and Improves Prognosis of Prostate Cancer.沙丁胺醇，一种短效β2受体激动剂，可降低前列腺癌风险并改善其预后。

Am J Clin Oncol. 2024 Dec 1;47(12):591-594. doi: 10.1097/COC.0000000000001134. Epub 2024 Jul 8.

Navigating duplication in pharmacovigilance databases: a scoping review.药物警戒数据库中重复数据的处理：范围综述。

BMJ Open. 2024 Apr 29;14(4):e081990. doi: 10.1136/bmjopen-2023-081990.

Abuse potential assessment of the dual orexin receptor antagonist daridorexant in rats.评估双重食欲素受体拮抗剂达理多雷克斯汀在大鼠体内的滥用潜力。

J Psychopharmacol. 2023 Dec;37(12):1249-1260. doi: 10.1177/02698811231215415. Epub 2023 Dec 7.

本文引用的文献

Data mining in spontaneous reports.自发报告中的数据挖掘

Basic Clin Pharmacol Toxicol. 2006 Mar;98(3):324-30. doi: 10.1111/j.1742-7843.2006.pto_232.x.

Data mining in pharmacovigilance: the need for a balanced perspective.药物警戒中的数据挖掘：需要一种平衡的视角。

Drug Saf. 2005;28(10):835-42. doi: 10.2165/00002018-200528100-00001.

Communication of findings in pharmacovigilance: use of the term "signal" and the need for precision in its use.药物警戒中研究结果的传达：“信号”一词的使用及其精确使用的必要性。

Eur J Clin Pharmacol. 2005 Jul;61(5-6):479-80. doi: 10.1007/s00228-005-0951-4. Epub 2005 Jul 1.

Evaluation of suspected adverse drug reactions.疑似药物不良反应的评估

JAMA. 2005 Mar 16;293(11):1324; author reply 1324-5. doi: 10.1001/jama.293.11.1324-a.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验